ABT
$105.46-1.73 (-1.61%)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medica...
Recent News
Is Abbott Laboratories (ABT) A Good Stock To Buy Now?
Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ Terwilliger. In this article, we will summarize the bulls’ thesis on ABT. Abbott Laboratories’s share was trading at $109.56 as of March 6th. ABT’s trailing and forward P/E were 29.45 and 19.30, respectively according to Yahoo […]
Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates
For years, the conversation around getting older has focused on individuals – retirement, lifestyle, healthcare. But a bigger story has been quietly unfolding in the background. The U.S. population itself is aging, and that shift is starting to ripple far beyond personal milestones. The Chief Investment Office at UBS views this trend as a foundation for long-term portfolio positioning. It frames “longevity” as a structural theme – a growing, aging population with evolving needs, particularly in
Sector Update: Health Care Stocks Retreat Late Afternoon
Health care stocks declined late Friday afternoon, with the NYSE Health Care Index and the State Str
Abbott to close $21B Exact Sciences acquisition Monday
Abbott said it has received all regulatory clearances necessary to buy the cancer screening firm.
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now
Don't give up on this leading dividend payer yet.